Q4 2021 Financial Results (Nasdaq: MRVI) February 23, 2022 LifeSciences Today's Agenda Welcome Deb Hart, Head of Investor Relations 01 Financial Results & Guidance Kevin Herde, Chief Financial Officer 02 Business Highlights & Update Carl Hull, Chief Executive Officer 03 04 Q&A Session Carl Hull, Chief Executive Officer Kevin Herde, Chief Financial Officer 2 Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains, and our officers and representatives may from time-to-time ...